ID : CBI_1597 | Updated on : | Author : CBI | Category : Healthcare
Heart Scan Market is estimated to reach over USD 19.20 Billion by 2032 from a value of USD 11.31 Billion in 2024 and is projected to grow by USD 11.85 Billion in 2025, growing at a CAGR of 6.2% from 2025 to 2032.
Heart scan, also known as cardiac scan, involves various non-invasive imaging tests, such as CT (Computed Tomography), nuclear, or ultrasound scans, which are capable of creating detailed pictures of the heart along with its blood vessels. The main purpose of a heart scan is to help diagnose as well as assess conditions such as coronary artery disease, heart damage, or any blockages in the heart. Moreover, the market involves the development, manufacturing, and sales of diagnostic technologies that are used for evaluating heart health, including various imaging devices along with its related software.
The incorporation of AI is considerably transforming the heart scan market. AI incorporation helps in improving diagnostic accuracy and efficiency, while also facilitating early detection of cardiovascular diseases. AI-powered systems are used for automating image analysis for a variety of scans, including echocardiograms and CT scans, for quickly measuring heart function and identifying disease markers, which can be more accurate and faster than manual measurements. Moreover, incorporation of AI-powered cardiac scanning systems offers several benefits including automated analytics, improved diagnostic capabilities, enhanced image quality and workflow, along with early risk prediction, among others. Hence, the above factors are expected to positively impact the market growth in the upcoming years.
The rising global prevalence of cardiovascular diseases is a primary factor driving the market. Cardiovascular diseases are among the leading causes of death worldwide. Several factors, including aging populations, sedentary lifestyles, unhealthy diets, rising obesity, along with increased stress, are contributing to the increasing incidence of heart conditions. This in turn, is driving the need for precise, non-invasive methods for assessing heart health, identifying any blockages, along with monitoring heart function, thereby driving the market.
Moreover, recent advancements in imaging technology, including AI-driven analysis, are making cardiac scans more accurate, faster, and safer. In addition, the growing focus on early detection of heart diseases, particularly for high-risk and asymptomatic patients, is further driving the market.
Thus, the rising incidence of cardiovascular diseases and rising focus on early detection of heart diseases are driving the heart scan market size.
The substantial cost associated with advanced cardiac scans, such as high-resolution CT and MRI, is considered to be a key barrier to market growth. Also, for many individuals, these diagnostic tests are financially prohibitive, particularly since insurance coverage for preventive screenings can be limited. In addition to the cost of equipment and maintenance, the procedures also require highly skilled professionals for accurate operation as well as interpretation, which in turn also increases costs. The above financial and operational barriers result in significant accessibility issues, particularly in low-income regions, rural areas, along with developing countries, where healthcare infrastructure may be limited. As a result, many at-risk individuals, who would benefit from early detection, are unable to access these essential diagnostic tools, which in turn may limit market expansion. Hence, the aforementioned factors are hindering the overall market growth.
The growing geriatric population worldwide is expected to offer lucrative aspects for market growth, as elderly patients usually have a higher incidence of cardiovascular diseases, more severe disease courses, along with increased mortality rates. Moreover, the global population of individuals aged 65 and older is expanding considerably, which in turn creates a large and vulnerable patient pool with a high prevalence of complex, age-related heart conditions like coronary artery disease, heart failure, and valvular disorders, among others. Heart scans including advanced CT, MRI, and echocardiography are essential diagnostic tools for elderly population as they offer non-invasive, precise methods for identifying structural and functional cardiac changes. This in turn, is increasing the demand for advanced diagnostic imaging services in hospitals, specialty cardiac centers, and other healthcare settings, thereby driving the market.
Hence, according to the analysis, the growing geriatric population is expected to drive the heart scan market opportunities.
Based on the type, the market is segmented into Echocardiogram (ECG), Computed Tomography (CT), Nuclear Heart Scan, Magnetic Resonance Imaging (MRI), Angiocardiography and Coronary Arteriography, and others.
Trends in the Type:
Echocardiogram (ECG) accounted for the largest revenue share in the year 2024.
Computed Tomography (CT) is anticipated to register the fastest CAGR during the forecast period.
Based on the indication, the market is bifurcated into coronary arteries blockage, structural heart disease, congenital heart disease, blood clots, arrhythmia, and others.
Trends in the Indication:
Coronary arteries blockage accounted for the largest revenue share in the year 2024.
Structural Heart Disease is anticipated to register the fastest CAGR during the forecast period.
Based on the end user, the market is segmented into Hospitals & Clinics, Diagnostic Centers/Imaging Centers, Ambulatory Surgical Centers (ASCs), Cardiac Care Centers, and Others.
Trends in the End User:
Hospitals & Clinics accounted for the largest revenue share of 55.25% in the year 2024 and is anticipated to register a significant CAGR during the forecast period.

The regions covered are North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Asia Pacific region was valued at USD 2.78 Billion in 2024. Moreover, it is projected to grow by USD 2.92 Billion in 2025 and reach over USD 4.93 Billion by 2032. Out of this, China accounted for the maximum revenue share of 33.52%. The market growth in the Asia Pacific region is primarily driven by the rising prevalence of cardiovascular diseases along with increasing investments in healthcare facilities, among others. Similarly, the rising development of hospitals, growing geriatric population, and advancements in diagnostic solutions for heart conditions are further driving the market in the region.

North America is estimated to reach over USD 7.20 Billion by 2032 from a value of USD 4.26 Billion in 2024 and is projected to grow by USD 4.46 Billion in 2025. The North American market is primarily driven by the increasing prevalence of cardiovascular diseases, caused by factors such as changing lifestyles and rising obesity rates, among others. Additionally, the increasing government expenditure on improving healthcare infrastructure and services is further propelling the market in the region.
The regional trends analysis depicts that factors including the prevalence of elderly population, growing healthcare industry, and robust healthcare and diagnostic infrastructure are driving the market in Europe. Additionally, key factors driving the market in Latin America, Middle East and African regions include increasing prevalence of cardiovascular diseases and other chronic heart conditions, combined with the increasing development of healthcare facilities including hospitals and clinics, and expanding access to improved healthcare services, among others.
The global heart scan market is highly competitive with major players providing solutions to the national and international markets. Key players are adopting several strategies in research and development (R&D), product innovation, and end-user launches to hold a strong position in the heart scan industry. Key players in the global heart scan market include-
Product Launches:
Partnerships & Collaborations:
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 19.20 Billion |
| CAGR (2025-2032) | 6.2% |
| By Type |
|
| By Indication |
|
| By End-user |
|
| By Region |
|
| Key Players |
|
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage |
|
The heart scan market is estimated to reach over USD 19.20 Billion by 2032 from a value of USD 11.31 Billion in 2024 and is projected to grow by USD 11.85 Billion in 2025, growing at a CAGR of 6.2% from 2025 to 2032.
The heart scan report includes specific segmentation details for, type, indication, end user, and regions.
In the heart scan market, Computed Tomography (CT) is the fastest-growing segment during the forecast period.
The key participants in the heart scan market are Siemens Healthineers AG (Germany), GE HealthCare (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Abbott Laboratories (US), Terumo Medical Corporation (Japan), Canon Medical Systems (Japan), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), Medtronic Inc. (US) and others.
The Heart Scan market is being shaped by several key trends including rapid integration of Artificial Intelligence (AI) to enhance diagnostic accuracy and workflow efficiency, growing adoption of non-invasive procedures, and the increasing use of portable and point-of-care ultrasound devices.